ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

NTP Board Oks Seven Compounds For Tests

April 22, 1983

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

R.S.K. Young Quits As FDA Oncology Group Leader

July 11, 1980

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000

Mammography Guidelines Tightened For BCDDP; September Consensus Meeting Planned

May 13, 1977